The prevalence of weight gain was 94% in women with macroprolactinomas, 59% in those with microprolactinomas, and 53% in patients with non-neoplastic hyperprolactinemia (e.g., functional or drug-induced hyperprolactinemia)
Sustainable synthesis of graphene oxide from waste sources: a comprehensive review of methods and applications
Recently, powerful GLP-1 agonist medications have surged in popularity as effective treatments for obesity
Tirzepatide is not recommended for individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or a known hypersensitivity to the medication
3) Add 1ml Binding/Wash Buffer to the tube and mix well, use the magnetic separation rack to collect the beads and discard the supernatant
Build your meals around nutrient-dense foods that are well-tolerated